Studies on aducanumab were halted earlier this year because the drug didn't appear to be effective. But the new results suggest it's effective at a high dose, the Associated Press reported.
from WebMD Health https://www.webmd.com/alzheimers/news/20191205/new-results-for-expiremental-alzheimers-drug?src=RSS_PUBLIC
0 Comments:
Post a Comment